Wendy Cheng

3.3k total citations
67 papers, 1.6k citations indexed

About

Wendy Cheng is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Wendy Cheng has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hepatology, 41 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in Wendy Cheng's work include Hepatitis C virus research (39 papers), Liver Disease Diagnosis and Treatment (30 papers) and Hepatitis B Virus Studies (21 papers). Wendy Cheng is often cited by papers focused on Hepatitis C virus research (39 papers), Liver Disease Diagnosis and Treatment (30 papers) and Hepatitis B Virus Studies (21 papers). Wendy Cheng collaborates with scholars based in Australia, United States and Canada. Wendy Cheng's co-authors include Lawrie W. Powell, Stuart K. Roberts, Dorothy H. Crawford, Edward Gane, William Sievert, June W. Halliday, Geoffrey W. McCaughan, Martin Weltman, Éric Sicard and W. G. E. Cooksley and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Wendy Cheng

62 papers receiving 1.6k citations

Peers

Wendy Cheng

HEPAT

EPIDE

IMMUN

Mark Danta Australia

Wolf Peter Hofmann Germany

Y. Benhamou France

Alexander Monto United States

Shahin Gharakhanian France

Greg Galler United States

Hugh Harley Australia

Tomoyuki Akita Japan

Vijayaprakash Suppiah Australia

Paul Richardson United Kingdom

Mark Danta Australia

Wendy Cheng

1.3k ×1.2

HEPAT

1.2k ×1.2

EPIDE

460 ×1.8

98 ×0.7

IMMUN

125 ×1.2

Citations per year, relative to Wendy Cheng Wendy Cheng (= 1×) peers Mark Danta

Countries citing papers authored by Wendy Cheng

Since Specialization

Citations

This map shows the geographic impact of Wendy Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Cheng more than expected).

Fields of papers citing papers by Wendy Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Cheng. The network helps show where Wendy Cheng may publish in the future.

Co-authorship network of co-authors of Wendy Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Cheng. A scholar is included among the top collaborators of Wendy Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Cheng. Wendy Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

So, Kenji, et al.. (2025). A pilot evaluation of the artificial intelligence system CAD-EYE to optically characterise lesions in inflammatory bowel disease surveillance. PubMed. 18. 2432641725–2432641725.

Huang, Yi‐Hsiang, Luis Calzadilla Bertot, Leon A. Adams, et al.. (2024). Natural History and Predictors of Clinical Outcomes in Autoimmune Liver Diseases: A Multicenter Study. Journal of Gastroenterology and Hepatology. 40(3). 731–740. 1 indexed citations

Clark, Paul J., Patricia C. Valery, Simone I. Strasser, et al.. (2023). Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care. Journal of Gastroenterology and Hepatology. 39(3). 568–575. 2 indexed citations

Venugopal, Kannan, et al.. (2023). Adherence to endoscopic surveillance guidelines for patients with inflammatory bowel disease: An Australian cohort study. Journal of Gastroenterology and Hepatology. 39(3). 506–511. 2 indexed citations

Gillespie, Iain, K. Arnold Chan, Yunhao Liu, et al.. (2022). Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database Study. Advances in Therapy. 40(2). 425–444. 2 indexed citations

Huang, Yi, John Joseph, W. Bastiaan de Boer, et al.. (2019). Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia. Clinical Gastroenterology and Hepatology. 18(2). 496–504.e3. 17 indexed citations

Nutescu, Edith A., Julio D. Duarte, Wendy Cheng, et al.. (2014). Abstract 16119: Novel Genotype Guided Personalized Warfarin Service Improves Outcomes in an Ethnically Diverse Population. Circulation. 130. 6 indexed citations

Agarwal, Kosh, Scott Fung, Tuan Nguyen, et al.. (2014). Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection. Journal of Hepatology. 62(3). 533–540. 144 indexed citations

Gane, Edward, Éric Sicard, Stuart C. Gordon, et al.. (2013). Safety and Pharmacodynamics of Oral TLR-7 agonist GS-9620 in patients with Chronic Hepatitis B. Hepatology. 58. 4 indexed citations

10.

Kitson, Matthew T., Gregory J. Dore, Jacob George, et al.. (2012). Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of Hepatology. 58(3). 467–472. 63 indexed citations

11.

Sievert, William, Gregory J. Dore, Geoffrey W. McCaughan, et al.. (2011). Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1. Hepatology. 53(4). 1109–1117. 29 indexed citations

12.

Lee, Silvia, James Flexman, Wendy Cheng, et al.. (2010). Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus.. SHILAP Revista de lepidopterología. 28(5). 273–80. 14 indexed citations

13.

Lee, Silvia, et al.. (2010). Increased proportion of the CD56^bright NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon‐αand ribavirin therapy. Journal of Medical Virology. 82(4). 568–574. 17 indexed citations

14.

Cheng, Wendy, et al.. (2008). Innovative practice in the management of chronic Hepatitis C: introducing the nurse practitioner model. Australian journal of advanced nursing. 25(4). 12 indexed citations

15.

Leedman, Peter J., Nickolas Kontorinis, James Flexman, et al.. (2008). Interferon‐induced thyroid dysfunction in chronic hepatitis C. Journal of Gastroenterology and Hepatology. 24(6). 1017–1023. 22 indexed citations

16.

Baker, Ross, et al.. (2008). Undiagnosed Myeloproliferative Disease in Cases of Intra-Abdominal Thrombosis: The Utility of the JAK2 617F Mutation. Clinical Gastroenterology and Hepatology. 6(4). 472–475. 9 indexed citations

17.

Gaudieri, Silvana, Andri Rauch, Katja Pfafferott, et al.. (2008). Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy #. Hepatology. 49(4). 1069–1082. 114 indexed citations

18.

Watson, Mark, Aleksandra Jaksic, Patricia Price, et al.. (2003). Interferon‐γ Response by Peripheral Blood Mononuclear Cells to Hepatitis C Virus Core Antigen Is Reduced in Patients with Liver Fibrosis. The Journal of Infectious Diseases. 188(10). 1533–1536. 9 indexed citations

19.

Powell, Elizabeth E., Michael P. Pender, J. B. Chalk, et al.. (1990). Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterology. 98(4). 1079–1082. 59 indexed citations

20.

Cheng, Wendy, Therese L. Murphy, Maree T. Smith, et al.. (1990). Dose-dependent pharmacokinetics of caffeine in humans: Relevance as a test of quantitative liver function. Clinical Pharmacology & Therapeutics. 47(4). 516–524. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact